{"ticker": "BOTA", "overview": {"cik": "72444", "ticker": "VXRT", "name": "Vaxart, Inc.", "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "sic": "2836", "announcements": [{"form": "4", "date": "2026-10-20", "title": "FORM 4", "accession": "0001437749-26-033037", "price_sensitive": false}, {"form": "3", "date": "2026-10-20", "title": "FORM 3", "accession": "0001437749-26-033036", "price_sensitive": false}, {"form": "8-K", "date": "2026-10-19", "title": "FORM 8-K", "accession": "0001437749-26-032932", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-14", "title": "FORM 8-K", "accession": "0001437749-26-030318", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-25", "title": "FORM 8-K", "accession": "0001437749-26-028916", "price_sensitive": true}, {"form": "10-Q", "date": "2026-08-06", "title": "FORM 10-Q", "accession": "0001437749-26-026289", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-06", "title": "FORM 8-K", "accession": "0001437749-26-026280", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-28", "title": "FORM 8-K", "accession": "0001437749-26-024560", "price_sensitive": true}, {"form": "4", "date": "2026-07-20", "title": "FORM 4", "accession": "0001437749-26-023863", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023810", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023809", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023808", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023807", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-17", "title": "FORM 8-K", "accession": "0001437749-26-023762", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-07", "title": "FORM 8-K", "accession": "0001437749-26-022876", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-06", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-075169", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-07-02", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-075088", "price_sensitive": false}, {"form": "DFAN14A", "date": "2026-07-02", "title": "Form DFAN14A", "accession": "0000921895-26-001714", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-02", "title": "CURRENT REPORT", "accession": "0001213900-26-074576", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-01", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-074234", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072735", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072727", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-26", "title": "FORM 8-K", "accession": "0001437749-26-021833", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072363", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072359", "price_sensitive": false}]}, "description": "BOTA trades as BOTA. Privy Trades holds 49 insider filings for the company, from June 2014 to February 2016. Across those, 5 insiders disclosed 9 open-market purchases totalling $570.81K. The most recent filing on record is dated 11 February 2016.", "exchange": null, "stats": {"buy_n": 9, "buy_sum": 570807.432, "sell_n": 0, "sell_sum": 0, "net": 570807.432, "insiders": 5, "first_date": "2014-06-11", "last_date": "2016-02-09"}, "metrics": {"ticker": "BOTA", "has_prices": false}, "trades": [{"id": "0001437749-16-026868", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Russell H. Plumb", "who_key": "PLUMB RUSSELL H", "role": "Chairman, Director", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774916026868/0001437749-16-026868-index.htm", "trade_date": "2016-02-11", "timestamp": "2016-02-11", "mins": 5641365}, {"id": "0001437749-16-025031", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Mark P. Colonnese", "who_key": "COLONNESE MARK P", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 9846.58, "score": 49.9, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Finance chief adds $10K of BOTA", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774916025031/0001437749-16-025031-index.htm", "trade_date": "2016-02-09", "timestamp": "2016-02-09", "mins": 5644245}, {"id": "0001437749-15-019484", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Mark P. Colonnese", "who_key": "COLONNESE MARK P", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CFO files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915019484/0001437749-15-019484-index.htm", "trade_date": "2015-11-02", "timestamp": "2015-11-02", "mins": 5786805}, {"id": "0001437749-15-017766", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Joseph M. Patti", "who_key": "PATTI JOSEPH M", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 9337.5, "score": 37.5, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO drops $9K on BOTA", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915017766/0001437749-15-017766-index.htm", "trade_date": "2015-09-25", "timestamp": "2015-09-25", "mins": 5841525}, {"id": "0001437749-15-018687", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Michael W. Dunne", "who_key": "Dunne Michael W.", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915018687/0001437749-15-018687-index.htm", "trade_date": "2015-09-21", "timestamp": "2015-09-21", "mins": 5847285}, {"id": "0001437749-15-018689", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Armando Anido", "who_key": "ANIDO ARMANDO", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915018689/0001437749-15-018689-index.htm", "trade_date": "2015-09-21", "timestamp": "2015-09-21", "mins": 5847285}, {"id": "0001437749-15-017466", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Russell H. Plumb", "who_key": "PLUMB RUSSELL H", "role": "Executive Chairman, Director", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 30228.600000000002, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915017466/0001437749-15-017466-index.htm", "trade_date": "2015-09-16", "timestamp": "2015-09-16", "mins": 5854485}, {"id": "0001437749-15-015753", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Peter Azzarello", "who_key": "Azzarello Peter", "role": "Chief Accounting Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915015753/0001437749-15-015753-index.htm", "trade_date": "2015-08-11", "timestamp": "2015-08-11", "mins": 5906325}, {"id": "0001437749-15-015755", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Anne Vanlent", "who_key": "VANLENT ANNE", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915015755/0001437749-15-015755-index.htm", "trade_date": "2015-08-11", "timestamp": "2015-08-11", "mins": 5906325}, {"id": "0001437749-15-015756", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Michael R. Dougherty", "who_key": "DOUGHERTY MICHAEL R", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915015756/0001437749-15-015756-index.htm", "trade_date": "2015-08-11", "timestamp": "2015-08-11", "mins": 5906325}, {"id": "0001437749-15-015757", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "John P. Richard", "who_key": "Richard John P", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915015757/0001437749-15-015757-index.htm", "trade_date": "2015-08-11", "timestamp": "2015-08-11", "mins": 5906325}, {"id": "0001437749-15-015758", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Geoffrey F. Cox", "who_key": "COX GEOFFREY F", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915015758/0001437749-15-015758-index.htm", "trade_date": "2015-08-11", "timestamp": "2015-08-11", "mins": 5906325}, {"id": "0001437749-15-015759", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Joseph M. Patti", "who_key": "PATTI JOSEPH M", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915015759/0001437749-15-015759-index.htm", "trade_date": "2015-08-11", "timestamp": "2015-08-11", "mins": 5906325}, {"id": "0001437749-15-012828", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Anne Vanlent", "who_key": "VANLENT ANNE", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 76891.5, "score": 37.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "BOTA draws its 3th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915012828/0001437749-15-012828-index.htm", "trade_date": "2015-06-22", "timestamp": "2015-06-22", "mins": 5978325}, {"id": "0001437749-15-012313", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "James Fox", "who_key": "Fox James", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 142100.0, "score": 55.9, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "That makes 4 insiders into BOTA", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915012313/0001437749-15-012313-index.htm", "trade_date": "2015-06-10", "timestamp": "2015-06-10", "mins": 5995605}, {"id": "0001437749-15-012169", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "James Fox", "who_key": "Fox James", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 139300.0, "score": 55.8, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The whole bench is buying BOTA \u2014 5 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915012169/0001437749-15-012169-index.htm", "trade_date": "2015-06-09", "timestamp": "2015-06-09", "mins": 5997045}, {"id": "0001437749-15-010163", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "James Fox", "who_key": "Fox James", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 16500.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915010163/0001437749-15-010163-index.htm", "trade_date": "2015-05-12", "timestamp": "2015-05-12", "mins": 6037365}, {"id": "0001437749-15-010164", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Geoffrey F. Cox", "who_key": "COX GEOFFREY F", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915010164/0001437749-15-010164-index.htm", "trade_date": "2015-05-12", "timestamp": "2015-05-12", "mins": 6037365}, {"id": "0001437749-15-010165", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "John P. Richard", "who_key": "Richard John P", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915010165/0001437749-15-010165-index.htm", "trade_date": "2015-05-12", "timestamp": "2015-05-12", "mins": 6037365}, {"id": "0001437749-15-010166", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Michael R. Dougherty", "who_key": "DOUGHERTY MICHAEL R", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915010166/0001437749-15-010166-index.htm", "trade_date": "2015-05-12", "timestamp": "2015-05-12", "mins": 6037365}, {"id": "0001437749-15-010167", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Anne Vanlent", "who_key": "VANLENT ANNE", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915010167/0001437749-15-010167-index.htm", "trade_date": "2015-05-12", "timestamp": "2015-05-12", "mins": 6037365}, {"id": "0001437749-15-006450", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Joseph M. Patti", "who_key": "PATTI JOSEPH M", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 45689.0, "score": 46.5, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "5 insiders now buying BOTA", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915006450/0001437749-15-006450-index.htm", "trade_date": "2015-03-27", "timestamp": "2015-03-27", "mins": 6103605}, {"id": "0001209191-14-061071", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Russell H. Plumb", "who_key": "PLUMB RUSSELL H", "role": "Vice Chairmen, Director", "person_type": "EXEC", "person_label": "Execs", "action": "NON-SIGNAL", "amount": 98000.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919114061071/0001209191-14-061071-index.htm", "trade_date": "2014-10-01", "timestamp": "2014-10-01", "mins": 6358485}, {"id": "0001209191-14-061073", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Joseph M. Patti", "who_key": "PATTI JOSEPH M", "role": "CEO and President", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919114061073/0001209191-14-061073-index.htm", "trade_date": "2014-10-01", "timestamp": "2014-10-01", "mins": 6358485}, {"id": "0001209191-14-061079", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Peter Azzarello", "who_key": "Azzarello Peter", "role": "Chief Accounting Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919114061079/0001209191-14-061079-index.htm", "trade_date": "2014-10-01", "timestamp": "2014-10-01", "mins": 6358485}, {"id": "0001209191-14-044367", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Joseph M. Patti", "who_key": "PATTI JOSEPH M", "role": "EVP, Corporate Dev & Strategy", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 14026.0, "score": 25.1, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "That makes 5 insiders into BOTA", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919114044367/0001209191-14-044367-index.htm", "trade_date": "2014-06-27", "timestamp": "2014-06-27", "mins": 6496725}, {"id": "0001209191-14-040906", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Joseph M. Patti", "who_key": "PATTI JOSEPH M", "role": "EVP, Corporate Dev & Strategy", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 37924.819, "score": 31.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "6 insiders now buying BOTA", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919114040906/0001209191-14-040906-index.htm", "trade_date": "2014-06-11", "timestamp": "2014-06-11", "mins": 6519765}, {"id": "0001209191-14-040912", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Russell H. Plumb", "who_key": "PLUMB RUSSELL H", "role": "CEO & President, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 95692.033, "score": 52.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 5 buying BOTA", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919114040912/0001209191-14-040912-index.htm", "trade_date": "2014-06-11", "timestamp": "2014-06-11", "mins": 6519765}, {"id": "0001209191-14-035451", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Geoffrey F. Cox", "who_key": "COX GEOFFREY F", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919114035451/0001209191-14-035451-index.htm", "trade_date": "2014-05-15", "timestamp": "2014-05-15", "mins": 6558645}, {"id": "0001209191-14-035453", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Michael R. Dougherty", "who_key": "DOUGHERTY MICHAEL R", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on BOTA \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919114035453/0001209191-14-035453-index.htm", "trade_date": "2014-05-15", "timestamp": "2014-05-15", "mins": 6558645}], "recent_buys": [{"id": "0001437749-16-025031", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Mark P. Colonnese", "who_key": "COLONNESE MARK P", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 9846.58, "score": 49.9, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Finance chief adds $10K of BOTA", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774916025031/0001437749-16-025031-index.htm", "trade_date": "2016-02-09", "timestamp": "2016-02-09", "mins": 5644245}, {"id": "0001437749-15-017766", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Joseph M. Patti", "who_key": "PATTI JOSEPH M", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 9337.5, "score": 37.5, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO drops $9K on BOTA", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915017766/0001437749-15-017766-index.htm", "trade_date": "2015-09-25", "timestamp": "2015-09-25", "mins": 5841525}, {"id": "0001437749-15-012828", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Anne Vanlent", "who_key": "VANLENT ANNE", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 76891.5, "score": 37.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "BOTA draws its 3th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915012828/0001437749-15-012828-index.htm", "trade_date": "2015-06-22", "timestamp": "2015-06-22", "mins": 5978325}, {"id": "0001437749-15-012313", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "James Fox", "who_key": "Fox James", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 142100.0, "score": 55.9, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "That makes 4 insiders into BOTA", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915012313/0001437749-15-012313-index.htm", "trade_date": "2015-06-10", "timestamp": "2015-06-10", "mins": 5995605}, {"id": "0001437749-15-012169", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "James Fox", "who_key": "Fox James", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 139300.0, "score": 55.8, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The whole bench is buying BOTA \u2014 5 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915012169/0001437749-15-012169-index.htm", "trade_date": "2015-06-09", "timestamp": "2015-06-09", "mins": 5997045}, {"id": "0001437749-15-006450", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Joseph M. Patti", "who_key": "PATTI JOSEPH M", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 45689.0, "score": 46.5, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "5 insiders now buying BOTA", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915006450/0001437749-15-006450-index.htm", "trade_date": "2015-03-27", "timestamp": "2015-03-27", "mins": 6103605}, {"id": "0001209191-14-044367", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Joseph M. Patti", "who_key": "PATTI JOSEPH M", "role": "EVP, Corporate Dev & Strategy", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 14026.0, "score": 25.1, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "That makes 5 insiders into BOTA", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919114044367/0001209191-14-044367-index.htm", "trade_date": "2014-06-27", "timestamp": "2014-06-27", "mins": 6496725}, {"id": "0001209191-14-040912", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Russell H. Plumb", "who_key": "PLUMB RUSSELL H", "role": "CEO & President, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 95692.033, "score": 52.1, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 5 buying BOTA", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919114040912/0001209191-14-040912-index.htm", "trade_date": "2014-06-11", "timestamp": "2014-06-11", "mins": 6519765}, {"id": "0001209191-14-040906", "src": "INSIDERS", "ticker": "BOTA", "cik": "72444", "company": "Vaxart, Inc.", "company_raw": "Biota Pharmaceuticals, Inc.", "who": "Joseph M. Patti", "who_key": "PATTI JOSEPH M", "role": "EVP, Corporate Dev & Strategy", "person_type": "EXEC", "person_label": "Execs", "action": "BUY", "amount": 37924.819, "score": 31.7, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "6 insiders now buying BOTA", "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919114040906/0001209191-14-040906-index.htm", "trade_date": "2014-06-11", "timestamp": "2014-06-11", "mins": 6519765}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "James Fox", "who_key": "Fox James", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 281400.0, "sold": 0, "net": 281400.0, "trades": 2, "top_score": 55.9, "lean": "buying", "history": [{"action": "BUY", "amount": 142100.0, "date": "2015-06-10", "score": 55.9, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915012313/0001437749-15-012313-index.htm"}, {"action": "BUY", "amount": 139300.0, "date": "2015-06-09", "score": 55.8, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915012169/0001437749-15-012169-index.htm"}], "latest": {"action": "BUY", "amount": 142100.0, "date": "2015-06-10", "score": 55.9, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915012313/0001437749-15-012313-index.htm"}}, {"who": "Joseph M. Patti", "who_key": "PATTI JOSEPH M", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "bought": 106977.319, "sold": 0, "net": 106977.319, "trades": 4, "top_score": 46.5, "lean": "buying", "history": [{"action": "BUY", "amount": 9337.5, "date": "2015-09-25", "score": 37.5, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915017766/0001437749-15-017766-index.htm"}, {"action": "BUY", "amount": 45689.0, "date": "2015-03-27", "score": 46.5, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915006450/0001437749-15-006450-index.htm"}, {"action": "BUY", "amount": 14026.0, "date": "2014-06-27", "score": 25.1, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919114044367/0001209191-14-044367-index.htm"}, {"action": "BUY", "amount": 37924.819, "date": "2014-06-11", "score": 31.7, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919114040906/0001209191-14-040906-index.htm"}], "latest": {"action": "BUY", "amount": 9337.5, "date": "2015-09-25", "score": 37.5, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915017766/0001437749-15-017766-index.htm"}}, {"who": "Russell H. Plumb", "who_key": "PLUMB RUSSELL H", "role": "CEO & President, Director", "person_type": "CEO", "person_label": "CEOs", "bought": 95692.033, "sold": 0, "net": 95692.033, "trades": 1, "top_score": 52.1, "lean": "buying", "history": [{"action": "BUY", "amount": 95692.033, "date": "2014-06-11", "score": 52.1, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919114040912/0001209191-14-040912-index.htm"}], "latest": {"action": "BUY", "amount": 95692.033, "date": "2014-06-11", "score": 52.1, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000120919114040912/0001209191-14-040912-index.htm"}}, {"who": "Anne Vanlent", "who_key": "VANLENT ANNE", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 76891.5, "sold": 0, "net": 76891.5, "trades": 1, "top_score": 37.7, "lean": "buying", "history": [{"action": "BUY", "amount": 76891.5, "date": "2015-06-22", "score": 37.7, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915012828/0001437749-15-012828-index.htm"}], "latest": {"action": "BUY", "amount": 76891.5, "date": "2015-06-22", "score": 37.7, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774915012828/0001437749-15-012828-index.htm"}}, {"who": "Mark P. Colonnese", "who_key": "COLONNESE MARK P", "role": "Chief Financial Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 9846.58, "sold": 0, "net": 9846.58, "trades": 1, "top_score": 49.9, "lean": "buying", "history": [{"action": "BUY", "amount": 9846.58, "date": "2016-02-09", "score": 49.9, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774916025031/0001437749-16-025031-index.htm"}], "latest": {"action": "BUY", "amount": 9846.58, "date": "2016-02-09", "score": 49.9, "source_url": "https://www.sec.gov/Archives/edgar/data/72444/000143774916025031/0001437749-16-025031-index.htm"}}], "activity": [], "announcements": [{"form": "4", "date": "2026-10-20", "title": "FORM 4", "accession": "0001437749-26-033037", "price_sensitive": false}, {"form": "3", "date": "2026-10-20", "title": "FORM 3", "accession": "0001437749-26-033036", "price_sensitive": false}, {"form": "8-K", "date": "2026-10-19", "title": "FORM 8-K", "accession": "0001437749-26-032932", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-14", "title": "FORM 8-K", "accession": "0001437749-26-030318", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-25", "title": "FORM 8-K", "accession": "0001437749-26-028916", "price_sensitive": true}, {"form": "10-Q", "date": "2026-08-06", "title": "FORM 10-Q", "accession": "0001437749-26-026289", "price_sensitive": true}, {"form": "8-K", "date": "2026-08-06", "title": "FORM 8-K", "accession": "0001437749-26-026280", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-28", "title": "FORM 8-K", "accession": "0001437749-26-024560", "price_sensitive": true}, {"form": "4", "date": "2026-07-20", "title": "FORM 4", "accession": "0001437749-26-023863", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023810", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023809", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023808", "price_sensitive": false}, {"form": "4", "date": "2026-07-17", "title": "FORM 4", "accession": "0001437749-26-023807", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-17", "title": "FORM 8-K", "accession": "0001437749-26-023762", "price_sensitive": true}, {"form": "8-K", "date": "2026-07-07", "title": "FORM 8-K", "accession": "0001437749-26-022876", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-06", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-075169", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-07-02", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-075088", "price_sensitive": false}, {"form": "DFAN14A", "date": "2026-07-02", "title": "Form DFAN14A", "accession": "0000921895-26-001714", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-02", "title": "CURRENT REPORT", "accession": "0001213900-26-074576", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-07-01", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-074234", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072735", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072727", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-26", "title": "FORM 8-K", "accession": "0001437749-26-021833", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072363", "price_sensitive": false}, {"form": "DEFA14A", "date": "2026-06-26", "title": "DEFINITIVE ADDITIONAL MATERIALS", "accession": "0001213900-26-072359", "price_sensitive": false}], "performance": {"ticker": "BOTA", "has_prices": false, "summary": null, "buys": [{"who": "COLONNESE MARK P", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Financial Officer", "amount": 9846.58, "date": "2016-02-09", "score": 49.9, "ref_price": null, "return": null}, {"who": "PATTI JOSEPH M", "person_type": "CEO", "person_label": "CEOs", "role": "CEO, Director", "amount": 9337.5, "date": "2015-09-25", "score": 37.5, "ref_price": null, "return": null}, {"who": "VANLENT ANNE", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 76891.5, "date": "2015-06-22", "score": 37.7, "ref_price": null, "return": null}, {"who": "Fox James", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 142100.0, "date": "2015-06-10", "score": 55.9, "ref_price": null, "return": null}, {"who": "Fox James", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 139300.0, "date": "2015-06-09", "score": 55.8, "ref_price": null, "return": null}, {"who": "PATTI JOSEPH M", "person_type": "CEO", "person_label": "CEOs", "role": "CEO, Director", "amount": 45689.0, "date": "2015-03-27", "score": 46.5, "ref_price": null, "return": null}, {"who": "PATTI JOSEPH M", "person_type": "EXEC", "person_label": "Execs", "role": "EVP, Corporate Dev & Strategy", "amount": 14026.0, "date": "2014-06-27", "score": 25.1, "ref_price": null, "return": null}, {"who": "PLUMB RUSSELL H", "person_type": "CEO", "person_label": "CEOs", "role": "CEO & President, Director", "amount": 95692.033, "date": "2014-06-11", "score": 52.1, "ref_price": null, "return": null}, {"who": "PATTI JOSEPH M", "person_type": "EXEC", "person_label": "Execs", "role": "EVP, Corporate Dev & Strategy", "amount": 37924.819, "date": "2014-06-11", "score": 31.7, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}